119 related articles for article (PubMed ID: 16501012)
1. Flecainide sensitivity of a Na channel long QT mutation shows an open-channel blocking mechanism for use-dependent block.
Zhu Y; Kyle JW; Lee PJ
Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H29-37. PubMed ID: 16501012
[TBL] [Abstract][Full Text] [Related]
2. Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome.
Abriel H; Wehrens XH; Benhorin J; Kerem B; Kass RS
Circulation; 2000 Aug; 102(8):921-5. PubMed ID: 10952963
[TBL] [Abstract][Full Text] [Related]
3. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
Sheets MF; Hanck DA
J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
[TBL] [Abstract][Full Text] [Related]
4. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
Wang GK; Russell C; Wang SY
J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
[TBL] [Abstract][Full Text] [Related]
5. Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide.
Nagatomo T; January CT; Makielski JC
Mol Pharmacol; 2000 Jan; 57(1):101-7. PubMed ID: 10617684
[TBL] [Abstract][Full Text] [Related]
6. State-dependent trapping of flecainide in the cardiac sodium channel.
Ramos E; O'leary ME
J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
[TBL] [Abstract][Full Text] [Related]
7. Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations.
Liu H; Tateyama M; Clancy CE; Abriel H; Kass RS
J Gen Physiol; 2002 Jul; 120(1):39-51. PubMed ID: 12084774
[TBL] [Abstract][Full Text] [Related]
8. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
9. Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues.
Liu H; Atkins J; Kass RS
J Gen Physiol; 2003 Mar; 121(3):199-214. PubMed ID: 12601084
[TBL] [Abstract][Full Text] [Related]
10. Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.
Desaphy JF; De Luca A; Didonna MP; George AL; Camerino Conte D
J Physiol; 2004 Jan; 554(Pt 2):321-34. PubMed ID: 14608015
[TBL] [Abstract][Full Text] [Related]
11. Preferential block of inactivation-deficient Na+ currents by capsaicin reveals a non-TRPV1 receptor within the Na+ channel.
Wang SY; Mitchell J; Wang GK
Pain; 2007 Jan; 127(1-2):73-83. PubMed ID: 16962240
[TBL] [Abstract][Full Text] [Related]
12. The role of the putative inactivation lid in sodium channel gating current immobilization.
Sheets MF; Kyle JW; Hanck DA
J Gen Physiol; 2000 May; 115(5):609-20. PubMed ID: 10779318
[TBL] [Abstract][Full Text] [Related]
13. Extracellular acidosis modulates drug block of Kv4.3 currents by flecainide and quinidine.
Singarayar S; Bursill J; Wyse K; Bauskin A; Wu W; Vandenberg J; Breit S; Campbell T
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):641-50. PubMed ID: 12875427
[TBL] [Abstract][Full Text] [Related]
14. Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
Desaphy JF; De Luca A; Tortorella P; De Vito D; George AL; Conte Camerino D
Neurology; 2001 Nov; 57(10):1849-57. PubMed ID: 11723275
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent block and resurgent tail currents induced by mouse beta4(154-167) peptide in cardiac Na+ channels.
Wang GK; Edrich T; Wang SY
J Gen Physiol; 2006 Mar; 127(3):277-89. PubMed ID: 16505148
[TBL] [Abstract][Full Text] [Related]
16. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
Ragsdale DS; McPhee JC; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9270-5. PubMed ID: 8799190
[TBL] [Abstract][Full Text] [Related]
17. Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells.
Grant AO; Chandra R; Keller C; Carboni M; Starmer CF
Biophys J; 2000 Dec; 79(6):3019-35. PubMed ID: 11106609
[TBL] [Abstract][Full Text] [Related]
18. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
20. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
